These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16823939)

  • 1. Surfactants in vaccine adjuvants: description and perspectives.
    Ascarateil S; Dupuis L
    Vaccine; 2006 Apr; 24 Suppl 2():S2-83-5. PubMed ID: 16823939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.
    Wong PT; Wang SH; Ciotti S; Makidon PE; Smith DM; Fan Y; Schuler CF; Baker JR
    Mol Pharm; 2014 Feb; 11(2):531-44. PubMed ID: 24320221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations.
    Devani M; Ashford M; Craig DQ
    J Pharm Pharmacol; 2004 Mar; 56(3):307-16. PubMed ID: 15025855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic assessment of the relationship between synthetic surfactants and mucosal adjuvanticity.
    Yoshino N; Kawamura H; Sugiyama I; Sasaki Y; Odagiri T; Sadzuka Y; Muraki Y
    Eur J Pharm Biopharm; 2021 Aug; 165():113-126. PubMed ID: 34004335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance.
    Hunter R; Strickland F; Kézdy F
    J Immunol; 1981 Sep; 127(3):1244-50. PubMed ID: 7264301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate--a revisit of the role of the hydrophile-lipophile balance (HLB) value.
    Yang YW; Wei AC; Shen SS
    Vaccine; 2005 Apr; 23(20):2665-75. PubMed ID: 15780450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
    Aucouturier J; Dupuis L; Deville S; Ascarateil S; Ganne V
    Expert Rev Vaccines; 2002 Jun; 1(1):111-8. PubMed ID: 12908518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4
    Schmidt ST; Neustrup MA; Harloff-Helleberg S; Korsholm KS; Rades T; Andersen P; Christensen D; Foged C
    Pharm Res; 2017 Aug; 34(8):1716-1727. PubMed ID: 28516400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrophilic-lipophilic balance, solubility parameter, and oil-water partition coefficient as universal parameters of nonionic surfactants.
    Schott H
    J Pharm Sci; 1995 Oct; 84(10):1215-22. PubMed ID: 8801337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility parameter and hydrophilic-lipophilic balance of nonionic surfactants.
    Schott H
    J Pharm Sci; 1984 Jun; 73(6):790-2. PubMed ID: 6737264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
    Gursoy RN; Benita S
    Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination adjuvants: the next generation of adjuvants?
    Mutwiri G; Gerdts V; van Drunen Littel-van den Hurk S; Auray G; Eng N; Garlapati S; Babiuk LA; Potter A
    Expert Rev Vaccines; 2011 Jan; 10(1):95-107. PubMed ID: 21162624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterocyclic cationic gemini surfactants: a comparative overview of their synthesis, self-assembling, physicochemical, and biological properties.
    Sharma VD; Ilies MA
    Med Res Rev; 2014 Jan; 34(1):1-44. PubMed ID: 22907528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic liposomes as vaccine adjuvants.
    Christensen D; Korsholm KS; Andersen P; Agger EM
    Expert Rev Vaccines; 2011 Apr; 10(4):513-21. PubMed ID: 21506648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics.
    Buyukozturk F; Benneyan JC; Carrier RL
    J Control Release; 2010 Feb; 142(1):22-30. PubMed ID: 19850092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable oil-in-water emulsions: preparation and use as vaccine vehicles for lipophilic adjuvants.
    Woodard LF; Jasman RL
    Vaccine; 1985 Jun; 3(2):137-44. PubMed ID: 4036272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone.
    Sek L; Boyd BJ; Charman WN; Porter CJ
    J Pharm Pharmacol; 2006 Jun; 58(6):809-20. PubMed ID: 16734982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
    Chauhan N; Tiwari S; Iype T; Jain U
    Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sweet surfactants: packing parameter-invariant amphiphiles as emulsifiers and capping agents for morphology control of inorganic particles.
    Voggel M; Meinusch RM; Siewert V; Kunkel M; Wittmann V; Polarz S
    Soft Matter; 2018 Sep; 14(35):7214-7227. PubMed ID: 30132500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some considerations about the hydrophilic-lipophilic balance system.
    Pasquali RC; Taurozzi MP; Bregni C
    Int J Pharm; 2008 May; 356(1-2):44-51. PubMed ID: 18258397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.